The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for Z Wen


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).EBI
Genentech
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties.EBI
Genentech
PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism.EBI
Nanjing University
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Structure-Activity Relationship of Heterocyclic P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Exploration of Alternative Scaffolds for P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase.EBI
Array Biopharma
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors.EBI
Array Biopharma
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationships.EBI
Arraybiopharma
A Hexylchloride-Based Catch-and-Release System for Chemical Proteomic Applications.BDB
University of Washington